Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-17-000273
Filing Date
2017-09-06
Accepted
2017-09-06 16:17:07
Documents
1
Period of Report
2017-09-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3842
  Complete submission text file 0000914190-17-000273.txt   5367
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REGENERX BIOPHARMACEUTICALS, INC. 3 BETHESDA METRO CENTER - SUITE 630 BETHESDA MD 20814
Business Address
Bove Mauro (Reporting) CIK: 0001396271 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 171071509